rs3775292

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000512264.1(TLR3):​c.-647C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.819 in 169,560 control chromosomes in the GnomAD database, including 57,248 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.82 ( 51758 hom., cov: 30)
Exomes 𝑓: 0.79 ( 5490 hom. )

Consequence

TLR3
ENST00000512264.1 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.278

Publications

36 publications found
Variant links:
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]
TLR3 Gene-Disease associations (from GenCC):
  • immunodeficiency 83, susceptibility to viral infections
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.856 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR3NM_003265.3 linkc.634-449C>G intron_variant Intron 3 of 4 ENST00000296795.8 NP_003256.1 O15455-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR3ENST00000296795.8 linkc.634-449C>G intron_variant Intron 3 of 4 1 NM_003265.3 ENSP00000296795.3 O15455-1

Frequencies

GnomAD3 genomes
AF:
0.823
AC:
125073
AN:
151920
Hom.:
51711
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.861
Gnomad AMI
AF:
0.809
Gnomad AMR
AF:
0.846
Gnomad ASJ
AF:
0.678
Gnomad EAS
AF:
0.877
Gnomad SAS
AF:
0.746
Gnomad FIN
AF:
0.907
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.793
Gnomad OTH
AF:
0.785
GnomAD4 exome
AF:
0.786
AC:
13767
AN:
17522
Hom.:
5490
Cov.:
0
AF XY:
0.783
AC XY:
7436
AN XY:
9500
show subpopulations
African (AFR)
AF:
0.861
AC:
205
AN:
238
American (AMR)
AF:
0.852
AC:
1912
AN:
2244
Ashkenazi Jewish (ASJ)
AF:
0.639
AC:
170
AN:
266
East Asian (EAS)
AF:
0.883
AC:
728
AN:
824
South Asian (SAS)
AF:
0.687
AC:
1183
AN:
1722
European-Finnish (FIN)
AF:
0.878
AC:
381
AN:
434
Middle Eastern (MID)
AF:
0.783
AC:
36
AN:
46
European-Non Finnish (NFE)
AF:
0.779
AC:
8525
AN:
10948
Other (OTH)
AF:
0.784
AC:
627
AN:
800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
137
274
410
547
684
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.823
AC:
125178
AN:
152038
Hom.:
51758
Cov.:
30
AF XY:
0.827
AC XY:
61421
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.861
AC:
35718
AN:
41470
American (AMR)
AF:
0.847
AC:
12938
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.678
AC:
2351
AN:
3470
East Asian (EAS)
AF:
0.877
AC:
4519
AN:
5150
South Asian (SAS)
AF:
0.745
AC:
3582
AN:
4810
European-Finnish (FIN)
AF:
0.907
AC:
9574
AN:
10560
Middle Eastern (MID)
AF:
0.728
AC:
214
AN:
294
European-Non Finnish (NFE)
AF:
0.793
AC:
53888
AN:
67978
Other (OTH)
AF:
0.785
AC:
1658
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1119
2239
3358
4478
5597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.815
Hom.:
6304
Bravo
AF:
0.822
Asia WGS
AF:
0.814
AC:
2833
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.6
DANN
Benign
0.50
PhyloP100
-0.28
PromoterAI
-0.054
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3775292; hg19: chr4-187003025; API